Clinical Trials in Peoria, Arizona

Find clinical trials in Peoria, Arizona. Discover local research opportunities and treatment options in your area.

36 Active Trials Found in Peoria

Showing 36 trials on this page

Page 2 of 2

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

NCT ID: NCT07009860

The RESTORE TRIAL is a clinical study designed to evaluate a new treatment called pemvidutide for people with Alcohol-Associated Liver Disease (ALD). This is a Phase 2 trial, meaning it's looking a...

Not yet recruiting

Phase: PHASE2 Conditions: Alcohol Liver Disease

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

NCT ID: NCT06419374

This clinical trial is studying a medication called pegozafermin to see how well it works and how safe it is for people with compensated cirrhosis caused by a liver condition known as Metabolic Dys...

Phase: PHASE3 Conditions: Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT ID: NCT05797610

This clinical trial is studying a new treatment called RO7434656 for patients with Primary IgA Nephropathy (IgAN), a kidney disease that can lead to serious complications. The main goal is to see i...

Phase: PHASE3 Conditions: Primary IgA Nephropathy

Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)

NCT ID: NCT06331312

This clinical trial is looking at the long-term safety and tolerability of a medication called secukinumab for patients with polymyalgia rheumatica (PMR), a condition that causes muscle pain and st...

Phase: PHASE3 Conditions: Polymyalgia Rheumatica

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)

NCT ID: NCT06846515

This clinical trial, called AR882-301, is studying a new treatment called AR882 for patients with gout, a type of arthritis that causes painful swelling in the joints. The main goal is to see if AR...

Phase: PHASE3 Conditions: Gout, Hyperuricemia +2 more

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Conditions: Lumbar Spinal Stenosis

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

Phase: PHASE3 Conditions: NASH With Fibrosis, MASH With Fibrosis

A Study of Baricitinib in Participants With Rheumatoid Arthritis

NCT ID: NCT04086745

This clinical trial is studying a medication called baricitinib to see how safe it is compared to another type of treatment for rheumatoid arthritis (RA) known as TNF inhibitors. Specifically, the ...

Phase: PHASE4 Conditions: Rheumatoid Arthritis

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

NCT ID: NCT04513717

The PREDICT-RT Trial is a clinical study aimed at finding the best treatment options for men with high-risk prostate cancer. The trial is testing two different approaches: for patients with a low g...

Phase: PHASE3 Conditions: Prostate Adenocarcinoma, Stage IVA Prostate Cancer AJCC v8 +1 more

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

NCT ID: NCT05050084

This clinical trial is designed to explore different treatment approaches for men with unfavorable intermediate risk prostate cancer. The trial uses a special test called the Decipher risk score to...

Phase: PHASE3 Conditions: Prostate Adenocarcinoma

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

NCT ID: NCT05896189

This clinical trial is looking at how effective computer-based cognitive training can be for breast cancer survivors who are experiencing problems with their thinking and memory, often referred to ...

Phase: NA Conditions: Breast Cancer, Cognitive Impairments

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

NCT ID: NCT06828055

This clinical trial is studying a new medication called VK2735 to see if it can help adults with obesity or overweight lose weight safely and effectively. The trial will last for 13 weeks and will ...

Phase: PHASE2 Conditions: Weight Loss

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

NCT ID: NCT06690398

This clinical trial is studying a medication called Lumateperone to see if it can help reduce irritability in children and teenagers aged 5 to 17 who have Autism Spectrum Disorder (ASD). The study ...

Phase: PHASE3 Conditions: Irritability Associated With Autism Spectrum Disorder

Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition

NCT ID: NCT06382662

This clinical trial is studying how two different medications, Metaxalone and Tizanidine, affect a person's ability to drive a truck and their thinking skills (cognition). Each participant will tak...

Phase: PHASE4 Conditions: Cognitive Impairment

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

NCT ID: NCT04028492

This clinical trial is studying a medication called tradipitant to see if it can help relieve nausea and other symptoms in people with gastroparesis, which is a condition that affects how the stoma...

Phase: PHASE3 Conditions: Gastroparesis, Diabetic Gastroparesis +1 more

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT ID: NCT04849728

This clinical trial, called NATiV3, is studying a new treatment called lanifibranor for adults with a liver condition known as Nonalcoholic Steatohepatitis (NASH) and fibrosis stages F2 or F3. NASH...

Phase: PHASE3 Conditions: NASH - Nonalcoholic Steatohepatitis

Search All Trials Browse All Locations